ABG Analytics logo
Get updates

Gilead Sciences Inc (NASDAQ: GILD)

DRUGS - Biotechnology
Sector: Health Care
Stock price data as of 04/03/2020
Closing price: 78.21
Support price level: $72.27
Resistance price level: N/A
Relative strength index (14-day RSI) 61.5
Beta 0.16
  • GILD is at or near its 52-week high. Studies have found that such stocks have an increased probability of outperforming the market over the next year.

  • GILD is one of this month's top performers with a return of -2.5 percent, beating 90 percent of stocks in the S&P-100.

  • Up 7.4 percent, GILD is one of this week's biggest gainers.

  • The price of this low-beta stock is expected to increase by 0.16% for every 1% increase in the S&P-500.

  • Volatility is forecast to fall over the next month.

  • Price broke above prior resistance level - a short-term bullish signal.

Low High Price as % of Range
$61.62 $80.22 90.4%
200 day 50 day 20 day 10 day
$66.70 $70.91 $73.74 $74.13
(Annualized standard deviation)
(5 year)
Last month Current estimate Next month forecast
28.2% 39.3% 56.8% 32.9%
There is an estimated 5% probability that the stock price of Gilead Sciences Inc will fall by more than:
  • 15.4% in the next week.

  • 18.6% in the next month.

  • 57.9% in the next year.